Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/1997
09/12/1997WO1997008199A3 Antimicrobial cationic peptides and methods of screening for the same
09/12/1997WO1997004097A3 Human CTLA-8 and uses of CTLA-8-related proteins
09/12/1997CA2248095A1 Transferrin receptor genes of moraxella
09/12/1997CA2248023A1 Process for the production of degradation and/or conversion products of storage substances present in transgenic plant material with the help of a malting process
09/12/1997CA2246333A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
09/12/1997CA2244733A1 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells
09/10/1997EP0794255A2 Method for cleaving chimeric protein using processing enzyme
09/10/1997EP0794251A1 D-pantolactone hydrolase and gene encoding the same
09/10/1997EP0793727A1 Production of variant nisin
09/10/1997EP0793722A2 Modified proteinase inhibitors
09/10/1997EP0793717A1 Oral immunization with transgenic plants
09/10/1997EP0793676A1 Novel membrane proteins of helicobacter pylori
09/10/1997EP0793672A1 Expressed chemokines, their production and uses
09/10/1997EP0793504A1 Chimeric cytokines and uses thereof
09/10/1997EP0793503A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
09/10/1997EP0793502A1 Novel hedgehog-derived polypeptides
09/10/1997EP0793501A1 In vivo activation of tumor-specific cytotoxic t cells
09/10/1997EP0568698B1 Process for producing cyclosporin a and/or c
09/10/1997EP0553357B1 Novel prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors
09/10/1997EP0546073B1 production and use of transgenic non-human animals capable of producing heterologous antibodies
09/10/1997CN1159206A Production and secretion of recombinant fibrinogen by yeast
09/09/1997US5665872 Dna having specified nucleotide sequence
09/09/1997US5665870 Method of purifying keratinocyte growth factor (KGF)
09/09/1997US5665869 Heating
09/09/1997US5665866 Process for obtaining antibodies utilizing heat treatment
09/09/1997US5665865 Metal binding proteins
09/09/1997US5665863 Coupled to albumin; genetic engineering
09/09/1997US5665862 Neurotrophic factor
09/09/1997US5665859 Molecules influencing the shedding of the TNF receptor, their preparation and their use
09/09/1997US5665593 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
09/09/1997US5665578 Vector and method for achieving high level of expression in eukaryotic cells
09/09/1997US5665570 Antibody-encoding recombinant DNA and its use
09/09/1997US5665567 Platelet-derived growth factor
09/09/1997US5665563 Enhanced protein production from a dna template
09/09/1997US5665552 Antibodies to plasmodium falciparum
09/09/1997US5665535 Polypeptides encoded by DNA sequences derived from the genome of the papillomavirus HPV39, antibodies thereto, and their use in in vitro diagnosis
09/09/1997US5665534 Method of detecting bovine diarrhoea virus infection, nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto
09/09/1997US5665357 Antibodies recognizing tumor associated antigen CA 55.1
09/09/1997US5665356 Human anti-Rh (D) monoclonal antibodies
09/09/1997CA1339445C Recombinant hybrid immunoglobulin molecules and method of use
09/04/1997WO1997032022A2 Canine ob protein compositions and methods
09/04/1997WO1997032019A2 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses
09/04/1997WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2)
09/04/1997WO1997022699A3 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof
09/04/1997WO1997016457A3 Anti-tumoral protein
09/04/1997CA2247503A1 Canine ob protein compositions and methods
09/03/1997EP0792886A1 Novel peptide and therapeutic agent
09/03/1997EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
09/03/1997EP0792368A1 Expression plasmids for yeasts
09/03/1997EP0792367A1 A dna construct encoding the yap3 signal peptide
09/03/1997EP0792365A1 Immunogens for stimulating mucosal immunity
09/03/1997EP0792363A1 Novel pesticidal proteins and strains
09/03/1997EP0792362A2 Sensory and motor neuron derived factor (smdf)
09/03/1997EP0792359A1 Transcription factor e2f-4
09/03/1997EP0792292A2 Orphan receptor
09/03/1997EP0792291A1 Protein affecting katp channels
09/03/1997EP0792290A1 Acylated insulin
09/03/1997EP0792288A1 Conjugates of bdnf and nt-3 with a water-soluble polymer
09/03/1997EP0792281A1 Process for purification of factor viii
09/03/1997EP0792279A1 Antibiotic cryptdin peptides and methods of their use
09/03/1997EP0792278A1 Tumor necrosis factor-gamma
09/03/1997EP0792168A1 Novel tumor suppressor gene, hic-1
09/03/1997EP0792162A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
09/03/1997EP0792160A1 Glial derived neurotrophic factor as a neuroprotective agent
09/03/1997EP0792155A1 Screening assay for anti-hiv drugs
09/03/1997EP0484374B1 Rapid, versatile and simple system for expressing genes in eukaryotic cells
09/03/1997CN1158639A DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme
09/03/1997CN1158623A New immunocotraceptive peptides
09/03/1997CN1158357A Gene regulating aureobasidin sensitivity
09/02/1997US5663304 Refolding of misfolded insulin-like growth factor-I
09/02/1997US5663303 Antibodies specific for retinoic acid receptor-γ
09/02/1997US5663301 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
09/02/1997US5663300 Protocadherin-42
09/02/1997US5663293 ICAM-related protein
09/02/1997US5663291 Process for obtaining insulin having correctly linked cystine bridges
09/02/1997US5663143 Protein which binds and inhibits elastase
09/02/1997US5663141 Hirudin/polyalkylene glycol conjugates and hirudin muteins
09/02/1997US5663070 Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM
09/02/1997US5663069 Modified lambda bacteriophage
09/02/1997US5663061 Expression vectors for the synthesis of proteins in the fission yeast schizosaccharomyces pombe
09/02/1997US5663060 Having procoagulant activity
09/02/1997US5662905 Protection against pseudomonas
09/02/1997US5662899 Prepared by culturing human monocytes and lymphocytes in a culture medium containing 1,25-dihydroxy vitamin d3 and granulocyte-macrophage colony stimulating factor
09/02/1997US5662895 Method of administering human pluripotent hematopoietic colony stimulating factor
09/02/1997CA1339416C Insulin derivatives
09/02/1997CA1339414C Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
08/1997
08/28/1997WO1997031123A1 Vmp-like sequences of pathogenic borrelia
08/28/1997WO1997031122A1 Substance fa-70d, process for producing the same, and uses thereof
08/28/1997WO1997031119A1 Methods and compositions for protective and therapeutic genetic immunization
08/28/1997WO1997031114A2 Polynucleotides and aminoacid sequences from staphylococcus aureus
08/28/1997WO1997031109A1 Meltrins
08/28/1997WO1997031099A1 Human beta 2 integrin alpha subunit
08/28/1997WO1997031024A1 Antibody variants
08/28/1997WO1997031010A1 Receptor protein designated 2f1
08/28/1997WO1997030722A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders
08/28/1997WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity
08/28/1997CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization
08/27/1997EP0791656A2 Platenolide synthase gene
08/27/1997EP0791653A1 Human Fc-gamma receptor III
08/27/1997EP0791652A1 Transgenic mammals expressing polypeptide-containing substances in their milk